Scarica l'app Stockscreener
6.92
0.00%
0.00
Dopo l'orario di chiusura:
6.96
0.04
+0.58%
Alpha Tau Medical Ltd Borsa (DRTS) Ultime notizie
DRTS SEC FilingsAlpha Tau Medical Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
Alpha Emitter Market Set to Boom Rapidly, Witnessing Strong - openPR.com
Piper Sandler cuts Alpha Tau Medical stock rating on valuation - Investing.com
Stop Loss: How does Alpha Tau Medical Ltd compare to its peersTrade Signal Summary & Weekly Breakout Stock Alerts - baoquankhu1.vn
Alpha Tau is Firing on All Cylinders: Japan Approval, 5 US Trials, And Now Pancreatic Data Heads to DDW - TipRanks
Alpha Tau Medical (DRTS) price target increased by 15.15% to 9.69 - msn.com
Aug Update: What is Alpha Tau Medical Ltd Equity Warrants market position2026 EndofYear Setup & Growth Focused Investment Plans - baoquankhu1.vn
Alpha Tau Wins First DDW Oral Slot for Alpha DaRT Pancreatic Cancer Data - TipRanks
Aug EndMonth: Why is Alpha Tau Medical Ltd stock going down2026 Sentiment & Daily Profit Maximizing Tips - baoquankhu1.vn
Alpha Tau Medical (Nasdaq: DRTS) wins DDW 2026 oral slot for Alpha DaRT pancreatic cancer trials - Stock Titan
Pancreatic cancer trial data from Jerusalem lands DDW podium slot - Stock Titan
Resistance Check: Is Alpha Tau Medical Ltd forming a bullish divergenceDollar Strength & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Aug Spikes: Should I invest in Alpha Tau Medical Ltd before earningsWeekly Trading Summary & Weekly Market Pulse Alerts - baoquankhu1.vn
Alpha Tau Medical Ltd. (NASDAQ:DRTS) Given Average Recommendation of "Hold" by Brokerages - marketbeat.com
Aug Ideas: Will Alpha Tau Medical Ltd Equity Warrant stock benefit from M AQuarterly Earnings Summary & Weekly Hot Stock Watchlists - baoquankhu1.vn
Oramed (NASDAQ: ORMP) pivots with Lifeward deal and Alpha Tau stake - Stock Titan
US Stocks Recap: What is Alpha Tau Medical Ltd Equity Warrants market positionMarket Movers & Community Verified Trade Signals - baoquankhu1.vn
Alpha Tau Medical Ltd. (DRTS) Competitors - Meyka
Alpha Tau Medical: 2026 Is The Breakthrough Year - Seeking Alpha
What is the Moat Score of Alpha Tau Medical Ltd2026 Closing Moves & Consistent Return Investment Signals - baoquankhu1.vn
Aug Action: Is Alpha Tau Medical Ltd Equity Warrant benefiting from interest rate changes2026 Winners & Losers & Safe Capital Growth Tips - baoquankhu1.vn
Is Alpha Tau Medical Ltd forming a bullish divergence2026 Year in Review & Real-Time Buy Signal Notifications - baoquankhu1.vn
Alpha Tau Medical (NASDAQ:DRTS) Shares Gap UpHere's Why - MarketBeat
Alpha Tau Medical Conference: Japan Approval, Rolling FDA PMA, and Big 2026 Data Readouts Teased - MarketBeat
Resistance Check: Is Alpha Tau Medical Ltd Equity Warrant benefiting from interest rate changesRate Hike & Daily Volume Surge Signals - baoquankhu1.vn
Alpha Tau Medical (DRTS) director details shares, options and RSUs - Stock Titan
Alpha Tau (DRTS) director discloses initial shares, RSUs and options - Stock Titan
Alpha Tau Medical (NASDAQ: DRTS) CEO details equity holdings - Stock Titan
Alpha Tau Medical (DRTS) director Alan Adler details share and option holdings - Stock Titan
Alpha Tau Medical (DRTS) director discloses shares, RSUs and options - Stock Titan
Alpha Tau Medical (DRTS) director details shares, options and warrants - Stock Titan
Alpha Tau Medical (NASDAQ: DRTS) director discloses initial shares, RSUs and option grants - Stock Titan
Alpha Tau Medical (NASDAQ: DRTS) director details initial equity holdings - Stock Titan
Alpha Tau Medical (DRTS) CFO Raphi Levy reports detailed insider holdings - Stock Titan
Pullback Watch: Can Alpha Tau Medical Ltd Equity Warrant reach all time highs this year2026 Top Gainers & Safe Swing Trade Setups - baoquankhu1.vn
Aug EndMonth: Will Alpha Tau Medical Ltd Equity Warrant benefit from rising consumer demandPortfolio Gains Report & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
Is Alpha Tau Medical Ltd stock showing strong momentum2026 Spike Watch & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Market Recap: Is Alpha Tau Medical Ltd Equity Warrant stock overvalued or fairly priced2026 Trading Volume Trends & Weekly Stock Breakout Alerts - baoquankhu1.vn
Alpha Tau to Present at Sidoti March Virtual Small Cap Conference - GlobeNewswire
Citigroup maintains Alpha Tau Medical (DRTS) buy recommendation - MSN
CFO Raphi Levy to pitch Alpha Tau to investors at Sidoti event this week - Stock Titan
Piper Sandler cuts Alpha Tau Medical stock rating on valuation By Investing.com - Investing.com Nigeria
Alpha Tau Medical’s innovative prostate cancer therapy: study completion update - MSN
Fund Flows: What is the PEG ratio of Alpha Tau Medical Ltd2026 Institutional Moves & Low Risk Entry Point Tips - baoquankhu1.vn
Citigroup Forecasts Strong Price Appreciation for Alpha Tau Medical (NASDAQ:DRTS) Stock - Defense World
HC Wainwright Has Negative Estimate for DRTS Q1 Earnings - Defense World
Short Squeeze: Will Alpha Tau Medical Ltd benefit from rate cuts2026 Fundamental Recap & Low Drawdown Momentum Ideas - baoquankhu1.vn
HC Wainwright Issues Pessimistic Estimate for DRTS Earnings - MarketBeat
Citigroup Increases Alpha Tau Medical (NASDAQ:DRTS) Price Target to $9.00 - MarketBeat
Alpha Tau Medical (NASDAQ:DRTS) Given Buy Rating at HC Wainwright - Defense World
HC Wainwright Reaffirms "Buy" Rating for Alpha Tau Medical (NASDAQ:DRTS) - MarketBeat
Alpha Tau Medical: U.S. Trial Expansion, Japan Approval, and Manufacturing Scale-Up Support Buy Rating Despite Near-Term Losses - TipRanks
Alpha Tau Medical (NASDAQ:DRTS) Issues Earnings Results, Misses Estimates By $0.01 EPS - MarketBeat
DRTS: Alpha DaRT shows promising efficacy in solid tumors, with pivotal trials and global expansion ongoing - TradingView
Alpha Tau Posts Wider 2025 Loss as Japanese Approval and U.S. Trial Progress Mark Pivotal Year - TipRanks
Alpha Tau Medical (NASDAQ: DRTS) outlines 2025 loss and Oramed financing - Stock Titan
Alpha Tau (NASDAQ: DRTS) widens 2025 loss but gains Japan approval, $76.9M cash - Stock Titan
Alpha Tau Medical Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Alpha Tau cancer therapy wins Japan nod, targets tough tumors - Stock Titan
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):